Allurion Technologies Inc. (ALUR | DoD: -1.61% | YTD: -76.61% | SmallCap: 20M)

• Profile: Focused on ending obesity with a weight loss platform to treat people who are overweight
• Clinical: Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS (Full Text)

Beyond Air, Inc. (XAIR | DoD: +0.96% | YTD: -50.00% | SmallCap: 16M)

• Profile: A company committed to revolutionizing nitric oxide therapy with the LungFit product family
• Regulatory: Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH (Full Text)

ENDRA Life Sciences Inc. (NDRA | DoD: -1.74% | YTD: -47.36% | SmallCap: 3M)

• Profile: A pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS¬Æ)
• Clinical: ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard (Full Text)

Helius Medical Technologies, Inc. (HSDT | DoD: -26.23% | YTD: -96.44% | SmallCap: 2M)

• Profile: A neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits
• Regulatory: Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device (Full Text)

Penumbra, Inc. (PEN | DoD: +1.74% | YTD: +8.74% | MidCap: 9.9B)

• Profile: The world's leading thrombectomy company
• Clinical: Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial (Full Text)

ProPhase Labs, Inc. (PRPH | DoD: +0.39% | YTD: -62.20% | SmallCap: 16M)

• Profile: Develops and commercializes novel drugs, dietary supplements, and compounds
• Clinical: ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer (Full Text)

Thermo Fisher Scientific Inc. (TMO | DoD: +0.58% | YTD: -22.34% | LargeCap: 148.8B)

• Profile: Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services
• Clinical: Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions (Full Text)

Castle Biosciences, Inc. (CSTL | DoD: +2.77% | YTD: -31.28% | SmallCap: 468M)

• Profile: A company improving health through innovative tests that guide patient care
• Collaboration: Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases (Full Text)

Charles River Laboratories International, Inc. (CRL | DoD: +1.06% | YTD: -17.31% | MidCap: 6.8B)

• Profile: Provides drug discovery, non-clinical development, and safety testing services
• Product: Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment (Full Text)

Hinge Health, Inc. (HNGE | DoD: +3.90% | YTD: -3.59% | MidCap: 3.3B)

• Profile: Develops health care software for joint and muscle health
• Product: Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care (Full Text)

Microbot Medical Inc. (MBOT | DoD: +4.70% | YTD: +114.91% | SmallCap: 97M)

• Profile: A company that develops and commercializes robotic technologies for endovascular procedures
• Patent: Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China (Full Text)

Orthofix Medical Inc. (OFIX | DoD: -0.64% | YTD: -36.67% | SmallCap: 432M)

• Profile: A leading global medical technology company
• Product: Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System (Full Text)

Quantum-Si incorporated (QSI | DoD: +6.63% | YTD: -58.45% | SmallCap: 324M)

• Profile: A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS)
• Product: Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston (Full Text)

SS Innovations International, Inc. (SSII | DoD: -8.47% | YTD: -58.46% | MidCap: 1.2B)

• Profile: Operates as a commercial-stage surgical robotics company
• Product: SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System (Full Text)

Waters Corporation (WAT | DoD: +1.61% | YTD: -5.55% | MidCap: 20.3B)

• Profile: Provides analytical workflow solutions 
• Product: Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity (Full Text)

Ainos, Inc. (AIMD | DoD: -0.08% | YTD: +0.72% | SmallCap: 14M)

• Profile: A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine
• Update: Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy (Full Text)

Applied DNA Sciences, Inc. (APDN | DoD: +9.52% | YTD: -97.24% | SmallCap: 38M)

• Profile: A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA)
• Announcement: Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August (Full Text)

Atlantic International Corp. (ATLN | DoD: +11.89% | YTD: -54.04% | SmallCap: 150M)

• Profile: Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals
• Announcement: Atlantic International Corp. Added to Membership of Russell 3000® Index (Full Text)

INVO Fertility, Inc. (IVF | DoD: +0.76% | YTD: -86.91% | SmallCap: 3M)

• Profile: Focuses on the fertility marketplace that provides assisted reproductive technology care to patients
• Award: INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025 (Full Text)

IQVIA Holdings Inc. (IQV | DoD: +1.50% | YTD: -18.38% | MidCap: 24.4B)

• Profile: Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries
• Award: IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement' (Full Text)

OncoCyte Corporation (OCX | DoD: +3.02% | YTD: +17.17% | SmallCap: 89M)

• Profile: Operates as a precision diagnostics company 
• Announcement: Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville (Full Text)

XWELL, Inc. (XWEL | DoD: -3.16% | YTD: -40.61% | SmallCap: 5M)

• Profile: Provides health and wellness services to travelers
• Announcement: XWELL Named Official Wellness Spa of the Orlando Magic (Full Text)

908 Devices Inc. (MASS | DoD: -1.64% | YTD: +228.31% | SmallCap: 227M)

• Profile: A commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets
• Leadership Update: 908 Devices Appoints Christopher D. Brown to its Board of Directors (Full Text)

Femasys Inc. (FEMY | DoD: +2.33% | YTD: -17.27% | SmallCap: 22M)

• Profile: A leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products
• Leadership Update: Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth (Full Text)